{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:38:18Z","timestamp":1789807098495,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic evidence suggests glioma risk is altered by leukocyte telomere length, allergic disease (asthma, hay fever or eczema), alcohol consumption, childhood obesity, low-density lipoprotein cholesterol (LDLc) and triglyceride levels. DNA methylation (DNAm) variation influences many of these glioma-related traits and is an established feature of glioma. Yet the causal relationship between DNAm variation with both glioma incidence and glioma risk factors is unknown. We applied a two-step Mendelian randomization (MR) approach and several sensitivity analyses (including colocalization and Steiger filtering) to assess the association of DNAm with glioma risk factors and glioma incidence. We used data from a recently published catalogue of germline genetic variants robustly associated with DNAm variation in blood (32,851 participants) and data from a genome-wide association study of glioma risk (12,488 cases and 18,169 controls, sub-divided into 6191 glioblastoma cases and 6305 non-glioblastoma cases). MR evidence indicated that DNAm at 3 CpG sites (cg01561092, cg05926943, cg01584448) in one genomic region (<jats:italic>HEATR3<\/jats:italic>) had a putative association with glioma and glioblastoma risk (False discovery rate [FDR]\u2009&lt;\u20090.05). Steiger filtering provided evidence against reverse causation. Colocalization presented evidence against genetic confounding and suggested that differential DNAm at the 3 CpG sites and glioma were driven by the same genetic variant. MR provided little evidence to suggest that DNAm acts as a mediator on the causal pathway between risk factors previously examined and glioma onset. To our knowledge, this is the first study to use MR to appraise the causal link of DNAm with glioma risk factors and glioma onset. Subsequent analyses are required to improve the robustness of our results and rule out horizontal pleiotropy.<\/jats:p>","DOI":"10.1038\/s41598-023-33621-1","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:03:15Z","timestamp":1682096595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of DNA methylation in the relationship between glioma risk factors and glioma incidence: a two-step Mendelian randomization study"],"prefix":"10.1038","volume":"13","author":[{"given":"Amy E.","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Relton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathreena M.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"issue":"2","key":"33621_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bjc.6602321","volume":"92","author":"NG Burnet","year":"2005","unstructured":"Burnet, N. G. et al. Years of life lost (YLL) from cancer is an important measure of population burden\u2013and should be considered when allocating research funds. Br. J. Cancer 92(2), 241\u2013245 (2005).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"33621_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1215\/15228517-2007-016","volume":"9","author":"S Larjavaara","year":"2007","unstructured":"Larjavaara, S. et al. Incidence of gliomas by anatomic location. Neuro. Oncol. 9(3), 319\u2013325 (2007).","journal-title":"Neuro. Oncol."},{"issue":"2","key":"33621_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000222090","volume":"33","author":"K Gousias","year":"2009","unstructured":"Gousias, K. et al. Descriptive epidemiology of cerebral gliomas in northwest Greece and study of potential predisposing factors, 2005\u20132007. Neuroepidemiology 33(2), 89\u201395 (2009).","journal-title":"Neuroepidemiology"},{"issue":"7","key":"33621_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom, Q. T. et al. The epidemiology of glioma in adults: A \u201cstate of the science\u201d review. Neuro Oncol. 16(7), 896\u2013913 (2014).","journal-title":"Neuro Oncol."},{"issue":"15","key":"33621_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.ejca.2015.07.032","volume":"51","author":"O Visser","year":"2022","unstructured":"Visser, O. et al. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur. J. Cancer. 51(15), 2231\u20132241 (2022).","journal-title":"Eur. J. Cancer."},{"key":"33621_CR6","unstructured":"UK, C.R. Survival for All Types of Brain Tumour. (2016). http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/brain-other-cns-and-intracranial-tumours\/incidence#collapseTen. Accessed 9 April 2018."},{"issue":"7","key":"33621_CR7","first-page":"976","volume":"19","author":"MKH Wiedmann","year":"2017","unstructured":"Wiedmann, M. K. H. et al. The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: A large prospective cohort study. Neuro Oncol. 19(7), 976\u2013985 (2017).","journal-title":"Neuro Oncol."},{"issue":"3","key":"33621_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/neuonc\/nov100","volume":"18","author":"C Seliger","year":"2016","unstructured":"Seliger, C. et al. Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol. 18(3), 340\u2013349 (2016).","journal-title":"Neuro Oncol."},{"issue":"8","key":"33621_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/annonc\/mdh306","volume":"15","author":"MPWA Houben","year":"2004","unstructured":"Houben, M. P. W. A. et al. Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann. Oncol. 15(8), 1256\u20131260 (2004).","journal-title":"Ann. Oncol."},{"issue":"20","key":"33621_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/jnci\/djm170","volume":"99","author":"E Linos","year":"2007","unstructured":"Linos, E. et al. Atopy and risk of brain tumors: A meta-analysis. J. Natl. Cancer Inst. 99(20), 1544\u20131550 (2007).","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"33621_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/1055-9965.EPI-09-0732","volume":"19","author":"CN Holick","year":"2010","unstructured":"Holick, C. N. et al. Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol. Biomark. Prev. 19(1), 39\u201347 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"33621_CR12","first-page":"197","volume":"105","author":"S Preston-Martin","year":"1991","unstructured":"Preston-Martin, S. & Mack, W. Gliomas and meningiomas in men in Los Angeles County: Investigation of exposures to N-nitroso compounds. IARC Sci. Publ. 105, 197\u2013203 (1991).","journal-title":"IARC Sci. Publ."},{"issue":"10","key":"33621_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/oxfordjournals.aje.a009201","volume":"146","author":"S Kaplan","year":"1997","unstructured":"Kaplan, S., Novikov, I. & Modan, B. Nutritional factors in the etiology of brain tumors: Potential role of nitrosamines, fat, and cholesterol. Am. J. Epidemiol. 146(10), 832\u2013841 (1997).","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"33621_CR14","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.18632\/oncotarget.6605","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao, L., Zheng, Z. & Huang, P. Diabetes mellitus and the risk of glioma: A meta-analysis. Oncotarget 7(4), 4483\u20134489 (2016).","journal-title":"Oncotarget"},{"issue":"9","key":"33621_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10654-016-0145-7","volume":"31","author":"C Seliger","year":"2016","unstructured":"Seliger, C. et al. Statin use and risk of glioma: Population-based case-control analysis. Eur. J. Epidemiol. 31(9), 947\u2013952 (2016).","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"33621_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000369814","volume":"44","author":"S Zhou","year":"2015","unstructured":"Zhou, S. et al. Association between vitamin C intake and glioma risk: Evidence from a meta-analysis. Neuroepidemiology 44(1), 39\u201344 (2015).","journal-title":"Neuroepidemiology"},{"issue":"7","key":"33621_CR17","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1097\/SCS.0000000000001707","volume":"26","author":"HX Li","year":"2015","unstructured":"Li, H. X. et al. A meta-analysis of association between pesticides exposure and glioma risk in adults. J. Craniofac. Surg. 26(7), e672\u2013e673 (2015).","journal-title":"J. Craniofac. Surg."},{"issue":"9","key":"33621_CR18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/ijc.28535","volume":"134","author":"ST Lee","year":"2014","unstructured":"Lee, S. T. et al. Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk. Int. J. Cancer 134(9), 2199\u20132210 (2014).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"33621_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bcp.12535","volume":"79","author":"L Andersen","year":"2015","unstructured":"Andersen, L. et al. Hormonal contraceptive use and risk of glioma among younger women: A nationwide case-control study. Br. J. Clin. Pharmacol. 79(4), 677\u2013684 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"33621_CR20","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10552-013-0178-0","volume":"24","author":"RB Little","year":"2013","unstructured":"Little, R. B. et al. Anthropometric factors in relation to risk of glioma. Cancer Causes Control 24(5), 1025\u20131031 (2013).","journal-title":"Cancer Causes Control"},{"issue":"2","key":"33621_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10552-012-0126-4","volume":"24","author":"S Malerba","year":"2013","unstructured":"Malerba, S. et al. A meta-analysis of coffee and tea consumption and the risk of glioma in adults. Cancer Causes Control 24(2), 267\u2013276 (2013).","journal-title":"Cancer Causes Control"},{"issue":"4","key":"33621_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ijc.25413","volume":"128","author":"GC Kabat","year":"2011","unstructured":"Kabat, G. C. et al. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP diet and health study. Int. J. Cancer 128(4), 944\u2013950 (2011).","journal-title":"Int. J. Cancer"},{"key":"33621_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fgene.2018.00525","volume":"9","author":"AE Howell","year":"2018","unstructured":"Howell, A. E. et al. Use of mendelian randomization for identifying risk factors for brain tumors. Front. Genet. 9, 525\u2013525 (2018).","journal-title":"Front. Genet."},{"issue":"1","key":"33621_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12885-020-06967-2","volume":"20","author":"AE Howell","year":"2020","unstructured":"Howell, A. E. et al. Testing for causality between systematically identified risk factors and glioma: A Mendelian randomization study. BMC Cancer 20(1), 508 (2020).","journal-title":"BMC Cancer"},{"issue":"2","key":"33621_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000323874","volume":"29","author":"JP Hamilton","year":"2011","unstructured":"Hamilton, J. P. Epigenetics: Principles and practice. Dig. Dis. 29(2), 130\u2013135 (2011).","journal-title":"Dig. Dis."},{"issue":"1","key":"33621_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/1471-2164-11-701","volume":"11","author":"A Etcheverry","year":"2010","unstructured":"Etcheverry, A. et al. DNA methylation in glioblastoma: Impact on gene expression and clinical outcome. BMC Genomics 11(1), 701 (2010).","journal-title":"BMC Genomics"},{"issue":"26","key":"33621_CR27","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat, D. J. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372(26), 2481\u20132498 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"33621_CR28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5), 510\u2013522 (2010).","journal-title":"Cancer Cell"},{"issue":"2","key":"33621_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ijc.30069","volume":"139","author":"A Mock","year":"2016","unstructured":"Mock, A. et al. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients. Int. J. Cancer 139(2), 424\u2013432 (2016).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"33621_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00401-014-1315-x","volume":"128","author":"B Wiestler","year":"2014","unstructured":"Wiestler, B. et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathol. 128(4), 561\u2013571 (2014).","journal-title":"Acta Neuropathol."},{"issue":"3","key":"33621_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/biom.12649","volume":"73","author":"EF Lock","year":"2017","unstructured":"Lock, E. F. & Dunson, D. B. Bayesian genome- and epigenome-wide association studies with gene level dependence. Biometrics 73(3), 1018\u20131028 (2017).","journal-title":"Biometrics"},{"issue":"4","key":"33621_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm, D. et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4), 425\u2013437 (2012).","journal-title":"Cancer Cell"},{"issue":"12","key":"33621_CR33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/neuonc\/nou138","volume":"16","author":"B Wiestler","year":"2014","unstructured":"Wiestler, B. et al. Assessing CpG island methylator phenotype, 1p\/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro Oncol. 16(12), 1630\u20131638 (2014).","journal-title":"Neuro Oncol."},{"key":"33621_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.18632\/oncotarget.13452","volume":"7","author":"MG Schliesser","year":"2016","unstructured":"Schliesser, M. G. et al. Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget 7, 50 (2016).","journal-title":"Oncotarget"},{"issue":"9","key":"33621_CR35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/neuonc\/noab023","volume":"23","author":"TS Sabedot","year":"2021","unstructured":"Sabedot, T. S. et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro Oncol. 23(9), 1494\u20131508 (2021).","journal-title":"Neuro Oncol."},{"key":"33621_CR36","first-page":"601245","volume":"2019","author":"H Noushmehr","year":"2019","unstructured":"Noushmehr, H. et al. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. BioRxiv 2019, 601245 (2019).","journal-title":"BioRxiv"},{"issue":"3","key":"33621_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaci.2020.11.044","volume":"147","author":"C-J Xu","year":"2021","unstructured":"Xu, C.-J. et al. Shared DNA methylation signatures in childhood allergy: The MeDALL study. J. Allergy Clin. Immunol. 147(3), 1031\u20131040 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"33621_CR38","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1038\/s41598-017-04493-z","volume":"7","author":"Y Dong","year":"2017","unstructured":"Dong, Y. et al. Associations between global DNA methylation and telomere length in healthy adolescents. Sci. Rep. 7(1), 4210 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"33621_CR39","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41598-019-38587-7","volume":"9","author":"F He","year":"2019","unstructured":"He, F. et al. Association between DNA methylation in obesity-related genes and body mass index percentile in adolescents. Sci. Rep. 9(1), 2079 (2019).","journal-title":"Sci. Rep."},{"issue":"10","key":"33621_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163067","volume":"11","author":"AM Dahlin","year":"2016","unstructured":"Dahlin, A. M. et al. Relation between established glioma risk variants and DNA methylation in the tumor. PLoS ONE 11(10), e0163067 (2016).","journal-title":"PLoS ONE"},{"issue":"1","key":"33621_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ije\/dyr233","volume":"41","author":"CL Relton","year":"2012","unstructured":"Relton, C. L. & Smith, G. D. Two-step epigenetic Mendelian randomization: A strategy for establishing the causal role of epigenetic processes in pathways to disease. Int. J. Epidemiol. 41(1), 161\u2013176 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"33621_CR42","first-page":"20180406","volume":"2020","author":"JL Min","year":"2020","unstructured":"Min, J. L. et al. Genomic and phenomic insights from an atlas of genetic effects on DNA methylation. MedRxiv 2020, 20180406 (2020).","journal-title":"MedRxiv"},{"issue":"21","key":"33621_CR43","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1158\/1078-0432.CCR-10-1502","volume":"16","author":"M Simon","year":"2010","unstructured":"Simon, M. et al. Genetic risk profiles identify different molecular etiologies for glioma. Clin. Cancer Res. 16(21), 5252\u20135259 (2010).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"33621_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ng.407","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41(8), 899\u2013904 (2009).","journal-title":"Nat. Genet."},{"issue":"2","key":"33621_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng.296","volume":"41","author":"T Rafnar","year":"2009","unstructured":"Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41(2), 221\u2013227 (2009).","journal-title":"Nat. Genet."},{"issue":"2","key":"33621_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11060-010-0506-0","volume":"104","author":"KM Egan","year":"2011","unstructured":"Egan, K. M. et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J. Neurooncol. 104(2), 535\u2013542 (2011).","journal-title":"J. Neurooncol."},{"key":"33621_CR47","doi-asserted-by":"publisher","first-page":"117693511982877","DOI":"10.1177\/1176935119828776","volume":"18","author":"JC Spainhour","year":"2019","unstructured":"Spainhour, J. C. et al. Correlation patterns between DNA methylation and gene expression in the cancer genome atlas. Cancer Inform. 18, 1176935119828776 (2019).","journal-title":"Cancer Inform."},{"issue":"2","key":"33621_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009359","volume":"5","author":"S Houshdaran","year":"2010","unstructured":"Houshdaran, S. et al. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS ONE 5(2), e9359 (2010).","journal-title":"PLoS ONE"},{"key":"33621_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jns.2017.07.048","volume":"380","author":"JS Young","year":"2017","unstructured":"Young, J. S. et al. Management of glioblastoma in elderly patients. J. Neurol. Sci. 380, 250\u2013255 (2017).","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"33621_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/hmg\/ddaa280","volume":"30","author":"RH Mulder","year":"2021","unstructured":"Mulder, R. H. et al. Epigenome-wide change and variation in DNA methylation in childhood: Trajectories from birth to late adolescence. Hum. Mol. Genet. 30(1), 119\u2013134 (2021).","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"33621_CR51","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1073\/pnas.1616556114","volume":"114","author":"M Klutstein","year":"2017","unstructured":"Klutstein, M. et al. Contribution of epigenetic mechanisms to variation in cancer risk among tissues. Proc. Natl. Acad. Sci. USA 114(9), 2230\u20132234 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"33621_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13059-016-1064-3","volume":"17","author":"Z Yang","year":"2016","unstructured":"Yang, Z. et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 17(1), 205 (2016).","journal-title":"Genome Biol."},{"issue":"5","key":"33621_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004919","volume":"12","author":"K Curtius","year":"2016","unstructured":"Curtius, K. et al. A molecular clock infers heterogeneous tissue age among patients with Barrett\u2019s esophagus. PLoS Comput. Biol. 12(5), e1004919 (2016).","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"33621_CR54","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamaoncol.2016.5945","volume":"3","author":"PC Haycock","year":"2017","unstructured":"Haycock, P. C. et al. Association between telomere length and risk of cancer and non-neoplastic diseases: A Mendelian randomization study. JAMA Oncol. 3(5), 636\u2013651 (2017).","journal-title":"JAMA Oncol."},{"issue":"5","key":"33621_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10(5), e1004383 (2014).","journal-title":"PLoS Genet."},{"issue":"1","key":"33621_CR56","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41598-021-82169-5","volume":"11","author":"JW Robinson","year":"2021","unstructured":"Robinson, J. W. et al. Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility. Sci. Rep. 11(1), 2329 (2021).","journal-title":"Sci. Rep."},{"issue":"10","key":"33621_CR57","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng, J. et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet. 52(10), 1122\u20131131 (2020).","journal-title":"Nat. Genet."},{"issue":"12","key":"33621_CR58","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1093\/hmg\/ddv077","volume":"24","author":"H Guo","year":"2015","unstructured":"Guo, H. et al. Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases. Hum. Mol. Genet. 24(12), 3305\u20133313 (2015).","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"33621_CR59","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ng.3330","volume":"47","author":"MD Fortune","year":"2015","unstructured":"Fortune, M. D. et al. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat. Genet. 47(7), 839\u2013846 (2015).","journal-title":"Nat. Genet."},{"issue":"11","key":"33621_CR60","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Smith, G. D. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLOS Genet. 13(11), e1007081 (2017).","journal-title":"PLOS Genet."},{"issue":"3","key":"33621_CR61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1214\/aoms\/1177731868","volume":"11","author":"A Wald","year":"1940","unstructured":"Wald, A. The fitting of straight lines if both variables are subject to error. Ann. Math. Stat. 11(3), 284\u2013300 (1940).","journal-title":"Ann. Math. Stat."},{"issue":"7","key":"33621_CR62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.annepidem.2006.12.005","volume":"17","author":"DC Thomas","year":"2007","unstructured":"Thomas, D. C., Lawlor, D. A. & Thompson, J. R. Re: Estimation of bias in nongenetic observational studies using \u201cMendelian triangulation\u201d by Bautista et al. Ann. Epidemiol. 17(7), 511\u2013513 (2007).","journal-title":"Ann. Epidemiol."},{"issue":"7","key":"33621_CR63","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37(7), 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"2","key":"33621_CR64","first-page":"85","volume":"183","author":"ES Amirian","year":"2016","unstructured":"Amirian, E. S. et al. The glioma international case-control study: A report from the genetic epidemiology of glioma international consortium. Am. J. Epidemiol. 183(2), 85\u201391 (2016).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"33621_CR65","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S., Thompson, S. G. & Collaboration, C. C. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40(3), 755\u2013764 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"33621_CR66","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ng.3823","volume":"49","author":"BS Melin","year":"2017","unstructured":"Melin, B. S. et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat. Genet. 49(5), 789\u2013794 (2017).","journal-title":"Nat. Genet."},{"key":"33621_CR67","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. MR-Base: A platform for systematic causal inference across the phenome using billions of genetic associations. BioRxiv (2016).","DOI":"10.1101\/078972"},{"key":"33621_CR68","first-page":"447367","volume":"2018","author":"U V\u00f5sa","year":"2018","unstructured":"V\u00f5sa, U. et al. Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis. Nat. Genet. 2018, 447367 (2018).","journal-title":"Nat. Genet."},{"issue":"1","key":"33621_CR69","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41467-018-04558-1","volume":"9","author":"T Qi","year":"2018","unstructured":"Qi, T. et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat. Commun. 9(1), 2282 (2018).","journal-title":"Nat. Commun."},{"issue":"23","key":"33621_CR70","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/bioinformatics\/bty476","volume":"34","author":"JL Min","year":"2018","unstructured":"Min, J. L. et al. Meffil: Efficient normalization and analysis of very large DNA methylation datasets. Bioinformatics 34(23), 3983\u20133989 (2018).","journal-title":"Bioinformatics"},{"issue":"15","key":"33621_CR71","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/bioinformatics\/bty147","volume":"34","author":"C Giambartolomei","year":"2018","unstructured":"Giambartolomei, C. et al. A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34(15), 2538\u20132545 (2018).","journal-title":"Bioinformatics"},{"issue":"18","key":"33621_CR72","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1093\/hmg\/ddy210","volume":"27","author":"TG Richardson","year":"2018","unstructured":"Richardson, T. G. et al. Systematic Mendelian randomization framework elucidates hundreds of CpG sites which may mediate the influence of genetic variants on disease. Hum. Mol. Genet. 27(18), 3293\u20133304 (2018).","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"33621_CR73","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10654-007-9152-z","volume":"22","author":"E Cardis","year":"2007","unstructured":"Cardis, E. et al. The INTERPHONE study: Design, epidemiological methods, and description of the study population. Eur. J. Epidemiol. 22(9), 647\u2013664 (2007).","journal-title":"Eur. J. Epidemiol."},{"issue":"14","key":"33621_CR74","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/hmg\/ddr192","volume":"20","author":"M Sanson","year":"2011","unstructured":"Sanson, M. et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum. Mol. Genet. 20(14), 2897\u20132904 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"33621_CR75","doi-asserted-by":"publisher","first-page":"8559","DOI":"10.1038\/ncomms9559","volume":"6","author":"B Kinnersley","year":"2015","unstructured":"Kinnersley, B. et al. Genome-wide association study identifies multiple susceptibility loci for glioma. Nat. Commun. 6, 8559 (2015).","journal-title":"Nat. Commun."},{"issue":"12","key":"33621_CR76","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","volume":"131","author":"P Rajaraman","year":"2012","unstructured":"Rajaraman, P. et al. Genome-wide association study of glioma and meta-analysis. Hum. Genet. 131(12), 1877\u20131888 (2012).","journal-title":"Hum. Genet."},{"issue":"8","key":"33621_CR77","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ng.408","volume":"41","author":"M Wrensch","year":"2009","unstructured":"Wrensch, M. et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41(8), 905\u2013908 (2009).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33621-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33621-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:04:36Z","timestamp":1682100276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33621-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33621"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33621-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6590"}}